Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Liquidia (LQDA)

Liquidia Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LQDA
DateTimeSourceHeadlineSymbolCompany
07/05/202413:30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
07/05/202413:00GlobeNewswire Inc.Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:LQDALiquidia Corporation
02/04/202414:00GlobeNewswire Inc.Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
01/04/202411:00GlobeNewswire Inc.Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
13/03/202410:00GlobeNewswire Inc.Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
06/03/202411:30GlobeNewswire Inc.Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:LQDALiquidia Corporation
05/03/202400:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
30/01/202411:30GlobeNewswire Inc.Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual CongressNASDAQ:LQDALiquidia Corporation
25/01/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
25/01/202411:00GlobeNewswire Inc.Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
23/01/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
19/01/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
19/01/202411:30GlobeNewswire Inc.Liquidia Corporation Announces Updates to Operations LeadershipNASDAQ:LQDALiquidia Corporation
16/01/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
16/01/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
16/01/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
16/01/202412:42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LQDALiquidia Corporation
08/01/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
08/01/202413:22GlobeNewswire Inc.Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files CounterclaimsNASDAQ:LQDALiquidia Corporation
05/01/202411:45GlobeNewswire Inc.Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
05/01/202402:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
04/01/202414:10GlobeNewswire Inc.Liquidia Corporation Announces $100 Million in New FinancingsNASDAQ:LQDALiquidia Corporation
04/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LQDALiquidia Corporation
02/01/202411:45GlobeNewswire Inc.Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
28/12/202321:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LQDALiquidia Corporation
22/12/202321:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LQDALiquidia Corporation
20/12/202322:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
20/12/202321:56GlobeNewswire Inc.U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)NASDAQ:LQDALiquidia Corporation
19/12/202301:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
14/12/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
 Showing the most relevant articles for your search:NASDAQ:LQDA